Market Research & HTA
We turn fragmented data on the Russia & CIS market into an evidence base for portfolio decisions - with a particular focus on the public sector, where the largest and most regulated share of demand is concentrated.
Who it's for
- Teams that need an objective read on the size, dynamics and potential of a niche before an investment decision
- Products building the value evidence base for the payer and the federal HTA review
- Portfolios that require regular analytics on public procurement and sales channels
What you get
Volumes, shares, dynamics and niche potential in Russia & the CIS - quantitative and qualitative.
Cost-effectiveness and budget impact analysis aligned with HTA review requirements.
RWD/RWE and the economic burden of disease to substantiate value.
Patient pathway, promotional practices and brand perception in the market.
Regular analytics - from public procurement to distributor data.
How we work
- 01
Scoping
1-2 weeksAligning hypotheses, data sources and success metrics for the study.
- 02
Data collection
3-5 weeksDesk research, work with the industry expert network, procurement data extracts.
- 03
Analysis & modelling
2-3 weeksQuantitative and qualitative analysis, potential assessment and scenarios.
- 04
Findings & recommendations
1 weekA report with prioritized recommendations and a results presentation.
Project example
Objective. Assessing the epidemiology and potential of rare diseases (haemophilia, Gaucher disease) for a manufacturer of clotting factors and enzyme-replacement therapy.
What we did. Ran quantitative and qualitative analysis, sized the target population and disease burden, and built a regular procurement reporting system.
Outcome. The client gained an evidence base to plan the portfolio and prioritize regions.
Let's discuss your case
We'll propose the best format and timeline for your product.